153 related articles for article (PubMed ID: 26170163)
1. A novel approach for predicting the dissolution profiles of pharmaceutical tablets.
Paus R; Hart E; Ji Y
Eur J Pharm Biopharm; 2015 Oct; 96():53-64. PubMed ID: 26170163
[TBL] [Abstract][Full Text] [Related]
2. Influence of excipients on solubility and dissolution of pharmaceuticals.
Paus R; Prudic A; Ji Y
Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
[TBL] [Abstract][Full Text] [Related]
3. A Novel Approach for Analyzing the Dissolution Mechanism of Solid Dispersions.
Ji Y; Paus R; Prudic A; Lübbert C; Sadowski G
Pharm Res; 2015 Aug; 32(8):2559-78. PubMed ID: 25715696
[TBL] [Abstract][Full Text] [Related]
4. DISSOLUTION PROPERTIES AND KINETIC STUDY OF SULFADIMIDINE AND TRIMETHOPRIM TABLETS CONTAINING FOUR DIFFERENT SUPERDISINTEGRANTS.
Zimmer Ł; Kasperek R; Poleszak E
Acta Pol Pharm; 2015; 72(2):347-55. PubMed ID: 26642686
[TBL] [Abstract][Full Text] [Related]
5. Biorelevant dissolution of poorly soluble weak acids studied by UV imaging reveals ranges of fractal-like kinetics.
Niederquell A; Kuentz M
Int J Pharm; 2014 Mar; 463(1):38-49. PubMed ID: 24406675
[TBL] [Abstract][Full Text] [Related]
6. Non-destructive determination of the coating film thickness by X-ray powder diffractometry and correlation with the dissolution behavior of film-coated tablets.
Yamada H; Terada K; Suryanarayanan R
J Pharm Biomed Anal; 2010 Mar; 51(4):952-7. PubMed ID: 19945243
[TBL] [Abstract][Full Text] [Related]
7. Population data analysis of dissolution time profiles: Assessment of physicochemical properties of the drug, drug particles and the pharmaceutical formulation.
Horkovics-Kovats S; Brunovský P; Pichler A; Bulitta JB
Eur J Pharm Sci; 2015 Oct; 78():245-54. PubMed ID: 26215465
[TBL] [Abstract][Full Text] [Related]
8. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
9. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
[TBL] [Abstract][Full Text] [Related]
10. Bilayer Tablet Dissolution Kinetics Based on a Degassing Cyclic Flow UV-Vis Spectroscopy with Chemometrics.
Otsuka Y; Ito A; Takahashi T; Matsumura S; Takeuchi M; Tanaka H
Chem Pharm Bull (Tokyo); 2019; 67(4):361-366. PubMed ID: 30930440
[TBL] [Abstract][Full Text] [Related]
11. Simultaneously Improving Mechanical, Formulation, and In Vivo Performance of Naproxen by Co-Crystallization.
Abbas N; Latif S; Afzal H; Arshad MS; Hussain A; Sadeeqa S; Bukhari NI
AAPS PharmSciTech; 2018 Oct; 19(7):3249-3257. PubMed ID: 30194682
[TBL] [Abstract][Full Text] [Related]
12. Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 1. Effect of tablet geometry in buffered medium.
Chakrabarti S; Southard MZ
J Pharm Sci; 1996 Mar; 85(3):313-9. PubMed ID: 8699336
[TBL] [Abstract][Full Text] [Related]
13. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous in vitro and in vivo evaluation of both trimethoprim and sulfamethoxazole from certain dosage forms.
Meshali M; El-Sabbagh H; Ghanem A; Foda A
Pharmazie; 1983 Jun; 38(6):403-6. PubMed ID: 6604284
[TBL] [Abstract][Full Text] [Related]
15. Influence of in vitro test conditions on release of aspirin from commercial tablets.
Nikolić L; Djurić Z; Jovanović M
J Pharm Sci; 1992 Apr; 81(4):386-91. PubMed ID: 1501078
[TBL] [Abstract][Full Text] [Related]
16. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
17. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.
Hughey JR; Keen JM; Miller DA; Kolter K; Langley N; McGinity JW
Eur J Pharm Sci; 2013 Mar; 48(4-5):758-66. PubMed ID: 23348153
[TBL] [Abstract][Full Text] [Related]
18. Control of poorly soluble drug dissolution in conditions simulating the gastrointestinal tract flow. 2. Cocompression of drugs with buffers.
Chakrabarti S; Southard MZ
J Pharm Sci; 1997 Apr; 86(4):465-9. PubMed ID: 9109050
[TBL] [Abstract][Full Text] [Related]
19. Dissolution characteristics of cylindrical particles and tablets.
Fukunaka T; Yaegashi Y; Nunoko T; Ito R; Golman B; Shinohara K
Int J Pharm; 2006 Mar; 310(1-2):146-53. PubMed ID: 16414218
[TBL] [Abstract][Full Text] [Related]
20. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL
Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
